Added value of prone position technique for PET-TAC in breast cancer patients;Valor añadido de la técnica en decúbito prono para el estudio con tomografía por emisión de positrones-tomografía computarizada en las pacientes con cáncer de mama

Revista Espanola de Medicina Nuclear

Volumn 29, Issue 5, 2010, Pages 230-235

  Vidal Sicart, S ^a,b,c   Aukema, T S ^b   Vogel, W V ^b   Hoefnagel, C A ^b   Valdes Olmos R A ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Breast cancer; Positron emission tomography computerized tomography; Prone decubitus position

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; AXILLARY LYMPH NODE; BODY POSTURE; BREAST CANCER; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; POSITRON EMISSION TOMOGRAPHY; SUPINE POSITION;

EID: 77956616842     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/S1578-200X(10)70026-7     Document Type: Article

References (28)

1. Maldonado A. Oncologic PET-TAC: The importance of a multidisciplinary team. Radiologia 2009, 51:6-14.
2. Kennedy J.A., Israel O., Frenkel A., Bar-Shalom R., Azhari H. Improved imaging fusion in PET/CT using hybrid image reconstruction and super-resolution. Int J Biomed Imaging 2007, 2007:46846.
3. Miles K.A., Williams R.E. Warburg revisited: Imaging tumour blood flow and metabolism. Cancer Imaging 2008, 8:81-86.
4. Straver ME, Aukema TS, Valdes-Olmos RA, Rutgers EJ, Gilhuijs KG, Schot ME, et al. Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients. Eur J Nucl Med Mol Imaging. 2010;37:1069-76.
5. Wright H., Listinsky J., Rim A., Chellman-Jeffers M., Patrick R., Rybiki L., et al. Magnetic resonance imaging as a diagnostic tool for breast cancer in premenopausal women. Am J Surg 2005, 190:572-575.
6. Liberman L., Morris E.A., Lee M.J., La Trenta L.R., Abramson A.F., Ballon D.J., et al. Breast lesions detected on MR imaging: Features and positive predictive value. Am J Radiol 2002, 179:171-178.
7. Hathaway P.B., Mankoff D.A., Maravilla K.R., Austin-Seymour M.M., Ellis G.K., Gralow J.R., et al. Value of combined FDG PET and mR imaging in the evaluation of suspect recurrent local-regional breast cancer: Preliminary experience. Radiology 1999, 210:807-814.
8. Palmedo H., Biersack H.J., Lastoria S., Maublant J., Prats E., Stegner H.E., et al. Scintimammography with technetium-99m methoxy isobutyllisonitrile: Results of prospective European multicentre trial. Eur J Nucl Med 1998, 25:375-385.
9. Tatsumi M., Cohade C., Mourtzikos K.A., Fishman E.K., Wahl R.L. Initial experience with FDG-PET/CT in the evaluation of breast cancer. Eur J Nucl Med Mol Imaging 2006, 33:254-262.
10. Walter C., Scheidhauer K., Scharl A., Goering U.J., Theissen P., Kugel H., et al. Clinical and diagnostic value of preoperative MR mammography and FDG-PET in suspicious breast lesions. Eur Radiol 2003, 13:1651-1656.
11. Goerres G.W., Michael S.C., Fehr M.K., Kaim A.H., Steinert H.C., Seifert B., et al. Follow-up of women with breast cancer: Comparison between MRI and FDG-PET. Eur Radiol 2003, 13:1635-1644.
12. Ueda S., Tsuda H., Asakawa H., Shigekawa T., Fukatsu K., Kondo N., et al. Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in primary breast cancer. Jpn J Clin Oncol 2008, 38:250-258.
13. Heusner TA, Kuemmel S, Hahn S, Koeninger A, Otterbach F, Hamami ME, et al. Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients. Eur J Nucl Med Mol Imaging. 2009;36:1543-50.
14. Duch J., Fuster D., Muñoz M., Fernández P.L., Paredes P., Fontanillas M., et al. 18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer. Eur J Nucl Med Mol Imaging 2009, 36:1551-1557.
15. Fletcher J.W., Djulbegovic B., Soares H.P., Siegel B.A., Lowe V.J., Lyman G.H. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 2008, 49:408-508.
16. Rosen E.L., Eubank W.B., Mankoff D.A. FDG PET, PET/CT and breast cancer imaging. Radiographics 2007, 27:S215-S229.
17. Yutani K., Tatsumi M., Uchara T., Nishihura T. Effect of patients' being prone during FDG PET for the diagnosis of breast cancer. Am J Radiol 1999, 173:1337-1339.
18. Rieber A., Schirmeister H., Gabelmann A., Nuessle K., Reske S., Kreienberg R., et al. Pre-operative staging of invasive breast cancer with MR mammography and/or PET: Boon or bunk?. Br J Radiol 2002, 75:789-798.
19. Moy L., Noz M.E., Maguire G.Q., Ponzo F, Deans A.E., Murphy-Walcott A.E., et al. Prone mammoPET acquisition improves the ability to fuse MRI and PET scans. Clin Nucl Med 2007, 32:194-198.
20. Kaida H., Ishibashi M., Fujii T., Murata S., Ogo E., Tanaka M., et al. Improved detection of breast cancer on FDG-PET cancer screening using breast positioning device. Ann Nucl Med 2008, 22:95-101.
21. Matthies A., Hicheson M., Cuchiara A., Alavi A. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 2001, 43:871-875.
22. Kumar R., Living V.A., Chauhan A., Zhuang H., Mitchell S., Alavia A., et al. Potential of dual-time-point imaging to improve breast cancer diagnosis with 18F-FDG PET. J Nucl Med 2005, 46:1819-1824.
23. Kaida H., Ishibashi M., Fuji T., Murata S., Uchida M., Baba K., et al. Improved breast cancer detection of prone breast fluorodeoxyglucose-PET in 118 patients. Nucl Med Commun 2008, 29:885-893.
24. Caprio M.G., Cangiano A., Imbriaco M., Soscia F., Di Martino G., Farina A., et al. Dual-time-point (18F)-FDG PET/CT in the diagnostic of suspicious breast lesions. Radiol Med 2010, En prensa.
25. Moy L., Ponzo F., Noz M.E., Maguire G.Q., Murphy-Walcott A.D., Deans A.E., et al. Improving specificity of breast MRI using prone PET and fused MRI and PET 3D volume datasets. J Nucl Med 2007, 48:528-537.
26. Fuster D., Duch J., Paredes P., Velasco M., Muñoz M., Santamaría G., et al. Preoperative staging of large primary breast cancer with fluordeoxyglucose positron emision tomography/computed tomography compared with conventional imaging procedures. J Clin Oncol 2008, 26:4746-4751.
27. Veronesi U., De Cicco C., Galimberti V.E., Fernández J.R., Rotmensz N., Viale G., et al. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol 2007, 18:473-478.
28. Tafra L. Positron emisión tomography (PET) and mammography (PEM) for breast cancer: Importance to surgeon. Ann Surg Oncol 2007, 14:3-13.